An important component of the hetIL-15 mediated anti-tumor effects in our study was the increased TILs and CD8+/Treg ratio in both MC38 and TC-1 tumors, suggesting that hetIL-15 may be a favorable immunotherapeutic intervention in tumors dependent on Tregs-suppressive functions. Here, CD8A is linked to neoplasm.